Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Transplantation Direct|October 8, 2025
Tocilizumab Treatment for Microvascular Inflammation and Chronic Active Antibody-mediated Rejection in Kidney TransplantationEdmund Huang, Michie Adjei, Alice Peng, et al.
Frontiers in Genetics|January 20, 2021
Single-Cell RNA Sequencing of Tocilizumab-Treated Peripheral Blood Mononuclear Cells as an <i>in vitro</i> Model of InflammationArya Zarinsefat, George Hartoularos, Dmitry Rychkov, et al.
Clinical Transplantation|September 17, 2020
The impact of belatacept on the phenotypic heterogeneity of renal T cell-mediated alloimmune response: The critical role of maintenance treatment and inflammatory loadDejan Dobi, Flavio Vincenti, Sindhu Chandran, et al.
Transplantation Direct|August 11, 2017
Refining the Policy for Timing of Kidney Transplant Waitlist QualificationBenjamin J Lee, Charles E McCulloch, Barbara A Grimes, et al.
The Journal of Biological Chemistry|September 9, 2011
Neural precursor cell-expressed developmentally down-regulated protein 4-2 (Nedd4-2) regulation by 14-3-3 protein binding at canonical serum and glucocorticoid kinase 1 (SGK1) phosphorylation sitesSindhu Chandran, Hui Li, Wuxing Dong, et al.
Frontiers in Immunology|October 7, 2021
Approaches to Establishing Tolerance in Immune Mediated DiseasesMichelle F Huffaker, Srinath Sanda, Sindhu Chandran, et al.
Transplantation Direct|June 5, 2026
CTLA4-Ig + Anti-IL-6/IL-6R Treatment Results in Long-term Allograft Survival and Function in Highly HLA-sensitized PatientsStanley C Jordan, Sindhu Chandran, Noriko Ammerman, et al.
The Journal of Biological Chemistry|May 15, 2010
Phosphopeptide screen uncovers novel phosphorylation sites of Nedd4-2 that potentiate its inhibition of the epithelial Na+ channelKenneth R Hallows, Vivek Bhalla, Nicholas M Oyster, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 11, 2024
Immunosuppression withdrawal in living-donor renal transplant recipients following induction with antithymocyte globulin and rituximab: Results of a prospective clinical trialJames F Markmann, Bryna E Burrell, Jonathan S Bromberg, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 29, 2020
Treatment of immunocompromised COVID-19 patients with convalescent plasmaMonica Fung, Ashok Nambiar, Suchi Pandey, et al.
Pageof 4